Last reviewed · How we verify
NCT06310707
Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter
NA trial testing ePatch ® Extended Wear Holter (EWH) in Arrythmia in 55 participants. Terminated before completion.
10 July 2025
Quick facts
| Lead sponsor | Philips Clinical & Medical Affairs Global |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 55 |
| Start date | 9 November 2023 |
| Primary completion | 10 July 2025 |
| Estimated completion | 10 July 2025 |
| Sites | 2 locations across France, Germany |
Drugs / interventions tested
- ePatch ® Extended Wear Holter (EWH)
Conditions studied
Sponsor
Philips Clinical & Medical Affairs Global — full company profile →
Who can join
18 and older, any sex, with Arrythmia or Syncope. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a Multi-center, prospective, randomized, unblinded, two-arm study to assess if 7-days of cardiac monitoring using the ePatch Holter results in identification of more clinically actionable arrythmia for patients with symptoms of syncope than standard 24 hour Holter monitoring.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06310707
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arrythmia
Currently open trials in the same condition.
- NCT06486818 — Clinical Predictors of Short Term Outcomes of Ablation of Idiopathic Monomorphic PVCs · recruiting
- NCT06425887 — Smartwatch Paroxysmal Arrhythmia Detection Compared with Holter · recruiting
- NCT06371937 — iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease · recruiting
- NCT06374277 — Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence · NA · recruiting
- NCT06266845 — Efficacy of Gamification With Escape-Room for Arrhythmia Identification in Critical Patients · NA · recruiting
Other Philips Clinical & Medical Affairs Global trials
Trials by the same sponsor.
- NCT07521735 — NEXT GEN - PHILIPS OPTIMUS · recruiting
- NCT07368036 — MR 7700 Multinuclear Application Clinical Trial · NA · not yet recruiting
- NCT07449715 — Respiration From Pleth Validation · recruiting
- NCT07317479 — Clinical Study for P-MAR · not yet recruiting
- NCT07317427 — Precise Image for Interventional CT · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06310707 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philips Clinical & Medical Affairs Global
- Last refreshed: 8 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06310707.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing